Policy & Sector Insights
Jul 23, 2019
Senate committee unveils ambitious plan to cap drug price hikes, out-of-pocket expenses
Stat News By LEV FACHER and NICHOLAS FLORKO JULY 23, 2019 WASHINGTON — A key Senate committee on Tuesday unveiled a long-awaited package of drug pricing reforms that would cap how much drug makers can hike their prices in Medicare. It would also cap out-of-pocket expenses for Medicare beneficiaries and dramatically reform the program’s prescription drug benefit.The bipartisan effort, […]
Jul 15, 2019
Generic drugs ‘wildly overpriced’ in Medicare, study finds
Becker’s Hospital Review Morgan Haefner – Monday, July 15th, 2019 Many generic drugs in Medicare Part D are “wildly overpriced,” according to an analysis from drug pricing research firm 46brooklyn. The report, which examined data from CMS’ Prescription Drug Plan Formulary, Pharmacy Network, and Pricing Information Files, found that while some generic drugs are priced fairly, others “show unbelievable […]
Jun 26, 2019
‘An Arm And A Leg’: Why Are Drug Prices So Random? Meet Mr. PBM
Kaiser Health News
Surely, an old-time, generic drug can’t cost $720 — for a three-month supply…Read More.
Jun 10, 2019
Drug middlemen name own prices, methodology goes unchallenged
The Columbus Dispatch
Ohio Medicaid officials and their managed-care contractors say they’re bringing new transparency to an opaque drug-delivery system that in 2017 saw more than a quarter-billion-dollar markup to taxpayers…Read More.
Jun 6, 2019
Two more big states take aim at PBM pricing practices, which one lawmaker calls ‘the wild west’
The controversial role that pharmacy benefit managers play in prescription drug pricing is under fresh attack in a pair of new reports issued by two of the largest state…Read More.
Jun 1, 2019
Consumers agree: Greater transparency among pharmacy benefit managers is needed
Recently, the Trump administration finalized a rule to require drug companies to disclose the list prices of their drugs in direct-to-consumer advertisements…Read More.
May 24, 2019
Parts Of HELP Bill Regulating PBMs Were Inspired By Montana Strategy
Inside Health Policy
Senate health committee chair Lamar Alexander (R-TN) and ranking Democrat Patty Murray (WA) included measures regulating pharmacy benefit managers in their draft bill on lowering health care costs that were inspired by a state official’s work in Montana…Read More.
May 1, 2019
States pursue aggressive drug pricing remedies; PBM, big pharma in crosshairs
States are taking aggressive actions to rein in high prescription treatment costs from pharmaceutical firms Opens a New Window. and curb potentially illicit behavior Opens a New Window. from middlemen price negotiators…Read More.